Maharashtra

endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India

by

Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence on the safety and efficacy of novel, short and all-oral regimens for the most difficult-to-treat … Read more

Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”

by

“We spent hundreds of rupees in private health clinics to trying to cure my tuberculosis, but none of the medication worked. The treatment included daily painful injections with lots of side-effects like vomiting, fatigue, loss of appetite… and sometimes even suicide,” says Rabiya, a 27-year-old woman with extremely-drug-resistant tuberculosis (XDR-TB). She is now a patient … Read more

World Tuberculosis Day: Treating the untreatable

by

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out more.

Mumbai: A new life with new tuberculosis drugs

by

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to nearly all drugs available. But access to these new life-saving drugs in India remains greatly … Read more